Pleuropulmonary blastoma is a rare embryonic malignant tumour that remains the most frequent malignant tumour of the lung in childhood. The International Pleuro pulmonary Blastoma Registry (IPPB) found only 220 cases in 2009 and 350 in 2015. In France, 20 cases were identified in 2009. Three histologies are described: type 1 purely cystic, type 2 combined and type 3 solid. Median age at diagnostic is 12 months, 35 months and 41 months respectively. Evolution is possible from type 1 to type 2 or 3 in 10% of the cases. Since 2009, DICER 1 mutations research is proposed systematically to all families. PPB symptoms are usually non-specific. Diagnostic is evoked when imaging work up shows bubbles or solid lesions, and confirmed by pathological analysis. However the diagnosis can be difficult because of the proximity with congenital cystic adenomatoid malformation. The French society of paediatric oncology recommends surgery at first instance. PPB type 1 remains a problem because some are still misdiagnosed as CCAM, a benign lesion. Chemotherapy depends on the PPB type and the quality of the resection. There is a real interest to analyse the French series. The prognosis of type 2 and 3 is low with a 5 years survival rate of 45-60%, whereas type 1 survival rate is 91%. The French experience reports a 100% survival rate in type 1 and 48% in type 2 and 3. Other prognostic factors are initial size of the tumour, extra pulmonary invasion and quality of surgery. Early local relapses are possible and late ones concern more often type 2 and 3 with more cerebral metastasis. In 2009, the french cases were collected, but no update has been performed since. The aim of this retrospective review of the cases since 2000, is to audit the care of PPB patients in France and update the French rare tumour database. Evoking PPB diagnosis is difficult when imaging shows a neonatal cystic lesion. There are no radiologic criteria in the literature that differentiate congenital pulmonary cystic lesion and PPB type 1. Radiological presentation is however overlapping. Another aim of this study will be to look for a predictive sign of type 1 PPB.
Multicentre retrospective study
Study Type
OBSERVATIONAL
Enrollment
41
Global current care
Angers University Hospital
Angers, France
Bordeaux University Hospital
Bordeaux, France
Caen University Hospital
Caen, France
Grenoble University Hospital
Grenoble, France
Kremlin-Bicêtre Hospital
Le Kremlin-Bicêtre, France
Lille University Hospital
Lille, France
Lyon Universty Hospital
Lyon, France
Marseille University Hospital
Marseille, France
Montpellier University Hospital
Montpellier, France
Nantes University Hospital
Nantes, France
...and 8 more locations
Overall survival
Time frame: Within 5 years from the diagnosis
Progression free survival
Characterize the evolution and the global care of PPB in the French series
Time frame: Within 5 years from the diagnosis
State of PPB surgical care
Time frame: Within 5 years from the diagnosis
Radiology sign
Identification of a type 1 PPB predictive radiological sign
Time frame: Within 5 years from the diagnosis
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.